Licarbazepine D4
| Product Name | Licarbazepine D4 |
|---|---|
| Alternate Names | Carbamazepine Stable Isotopes, Stable Isotopes of Carbamazepine |
| CAT No. | CS-O-14126 |
| CAS No. | 1020719-39-4 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 258.31 g/mol |
| Mol. For. | C₁₅H₁₀D₄N₂O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Carbamazepine |
| Purity | Not less than 90 % |
| Therapeutic | Anticonvulsants (Anti-Epileptics) |
| Smileys | NC(N(C1=C(C([2H])=C2[2H])[2H])C3=CC=CC=C3C(O)CC1=C2[2H])=O |
| Canonical Smiles | C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O |
| InchIKey | BMPDWHIDQYTSHX-DNZPNURCSA-N |
| Inchl | InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/i1D,3D,5D,7D |
| IUPAC | 1,2,3,4-tetradeuterio-6-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Licarbazepine D4 is a labeled analog of Licarbazepine, a medication used to treat epilepsy. It is a derivative of Carbamazepine, which is a commonly used antiepileptic drug. Licarbazepine D4 is used in clinical trials and research studies to study the pharmacokinetics and pharmacodynamics of Licarbazepine.
Chemically, Licarbazepine D4 is a deuterated version of Licarbazepine, which means that it contains four deuterium atoms instead of hydrogen atoms. Deuterium is a stable isotope of hydrogen, and its incorporation into drugs can improve their metabolic stability and reduce their toxicity. The molecular formula of Licarbazepine D4 is C15H9D4N2O2.
Licarbazepine D4 is typically administered orally in tablet form, and its dosage varies depending on the patient's age, weight, and medical condition. It is metabolized in the liver by cytochrome P450 enzymes, and its metabolites are excreted in the urine. Like most antiepileptic drugs, Licarbazepine D4 may cause side effects such as dizziness, nausea, headache, and fatigue.
In conclusion, Licarbazepine D4 is a useful tool for studying the pharmacology of Licarbazepine. Its stable isotope labeling provides valuable information on the drug's metabolism and distribution in the body. With further research, Licarbazepine D4 could potentially lead to the development of safer and more effective antiepileptic drugs.
Get an Instant Quote
Related Compounds
Carbamazepine 10,11-Epoxide-d8 (Major) |